-
A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients with Primary IgA Nephropathy at ...
The research study is being conducted to see how well the investigational drug, Nefecon, works for the treatment of your ...Exact
Phase 
-
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA ...
This study will use a new investigational study drug called OMS721 in people with Immunoglobulin A (IgA) Nephropathy. This kidney ...Exact
Phase
-
A Phase 2 Multicenter, Open Label, Randomized Study of Two Titration Regimens of Oral CXA-10 in Subjects with Primary Focal ...
Primary FSGS is a progressive disease that causes the kidneys to scar, to leak protein into the urine and may ...
Exact
Phase 
-
The Nephrotic Syndrome Study Network
The Nephrotic Syndrome Study Network (NEPTUNE) is a multi-disciplinary, multi-center longitudinal observational study. The main purpose of this study is ...
Exact
-
An Open-Label Phase 2 Proof or Concept Study in Patients with C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN) Treated ...
This is an open-label study of 12 months of dosing with ACH-0144471. The study will enroll patients with biopsy-confirmed C3G ...
Free text
Phase
-
Free text
Phase
Showing - of trials